Antibodies against gentamicin associated with increased risk of type 1 diabetes in children

Antibodies produced against the commonly used antibiotic, gentamicin, appear to increase the risk of type 1 diabetes in children already genetically at risk, scientists say. When Medical College of Georgia scientists compared the blood of nearly 300 individuals with type 1 diabetes to healthy controls, they found that a higher level of antibodies against gentamicin was associated with increased risk […]

Continue reading »

Scientists reveal the role of immune progenitor cells in the repair of inflamed intestinal tissue

The human body contains an array of coexisting commensal microbes, primarily gut bacteria, which have been linked to the regulation of hematopoiesis, or the production of blood and its components (including immune cells). However, how the hematopoietic system manages microbial signals and maintains tissue integrity in the presence of inflammation is still unknown. Scientists from Kumamoto University in Japan now […]

Continue reading »

The Native Antigen Company expands infectious disease portfolio to include Sudan Ebolavirus Boniface 1976 Glycoprotein

The Native Antigen Company (part of LGC Clinical Diagnostics), one of the world's leading suppliers of reagents that enables research into vaccines and diagnostics for emerging and endemic infectious diseases, today announced the commercial release of its Sudan Ebolavirus Boniface 1976 Glycoprotein (SEBOV GP). The addition of this latest recombinant protein expands the Company's comprehensive portfolio of antigens and antibodies […]

Continue reading »

Antibodies to common antibiotic possible new risk factor for type 1 diabetes

Antibodies produced against the commonly used antibiotic, gentamicin, appear to increase the risk of type 1 diabetes in children already genetically at risk, scientists say. When Medical College of Georgia scientists compared the blood of nearly 300 individuals with type 1 diabetes to healthy controls, they found that a higher level of antibodies against gentamicin was associated with increased risk […]

Continue reading »

The potential benefit of metformin to reduce delirium risk and mortality

A new research paper titled “The potential benefit of metformin to reduce delirium risk and mortality: a retrospective cohort study” has been published in Aging. Metformin has been reported to improve age-related disorders, including dementia, and to lower mortality. This study was conducted to investigate whether metformin use lowers delirium risk, as well as long-term mortality. In the current retrospective […]

Continue reading »
1 266 267 268 269 270 1,322